Preconception use of cART by HIV-positive pregnant women increases the risk of infants being born small for gestational age.
- Ingrid J M Snijdewind
- Colette Smit
- Mieke H Godfried
- Rachel Bakker
- Jeannine F J B Nellen
- Vincent W V Jaddoe
- Elisabeth van Leeuwen
- Peter Reiss
- Eric A P Steegers
- Marchina E van der Ende
DOIAbstract
The benefits of combination anti-retroviral therapy (cART) in HIV-positive pregnant women (improved maternal health and prevention of mother to child transmission [pMTCT]) currently outweigh the adverse effects due to cART. As the variety of cART increases, however, the question arises as to which type of cART is safest for pregnant women and women of childbearing age. We studied the effect of timing and exposure to different classes of cART on adverse birth outcomes in a large HIV cohort in the Netherlands.We included singleton HEU infants registered in the ATHENA cohort from 1997 to 2015. Multivariate logistic regression analysis for single and multiple pregnancies was used to evaluate predictors of small for gestational age (SGA, birth w...
Add to ORKG